Drug indexes gain as Inspire tanks on study
January 03, 2011 at 10:48 AM EST
Shares of Inspire Pharmaceuticals are tanking on a failed late-stage study for its cystic fibrosis drug denufosol.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.